Stock comparison
Caris Life Sciences, Inc. is 1.2x more valuable than RadNet, Inc. by market capitalization ($7.02 B vs $5.66 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
CAI is larger
Caris Life Sciences, Inc. is 1.2x more valuable than RadNet, Inc. by market capitalization ($7.02 B vs $5.66 B).
Market value leader
CAI
Caris Life Sciences, Inc. is 1.2x more valuable than RadNet, Inc. by market capitalization ($7.02 B vs $5.66 B).
Revenue leader
RDNT
CAI: $812.03M vs RDNT: $2.04B.
Profit leader
RDNT
CAI: -$68.09M vs RDNT: -$18.65M.
Margin leader
RDNT
CAI: -8.4% vs RDNT: -0.9% net margin.
| Metric | CAI | RDNT |
|---|---|---|
| Market cap | $7.02 B | $5.66 B |
| US-listed rank | #1173 | #1328 |
| Revenue (latest FY) | $812.03M | $2.04B |
| Net income (latest FY) | -$68.09M | -$18.65M |
| Net margin | -8.4% | -0.9% |
| P/E (trailing FY) | - | - |
| SEC filings | 102 | 1,345 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Caris Life Sciences, Inc. is 1.2x more valuable than RadNet, Inc. by market capitalization ($7.02 B vs $5.66 B).
In their latest fiscal years, Caris Life Sciences, Inc. reported $812.03M in revenue while RadNet, Inc. reported $2.04B.
Full pages: Caris Life Sciences, Inc. and RadNet, Inc., or browse the full rankings.